Stock Earnings

Question 1

Quels sont les états financiers clés de Silence Therapeutics PLC ?

Accepted Answer

Selon le dernier état financier (Form-10K), Silence Therapeutics PLC a un total d'actifs de $0, un bénéfice net loss de $0

Question 2

Quels sont les ratios financiers clés pour SLN ?

Accepted Answer

Le ratio de liquidité de Silence Therapeutics PLC est 0, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de Silence Therapeutics PLC sont-ils répartis par segment ou géographie ?

Accepted Answer

Silence Therapeutics PLC largest revenue segment is Ribonucleic Acid Therapeutics, at a revenue of 42,353,702 in the most earnings release.For geography, United Kingdom is the primary market for Silence Therapeutics PLC, at a revenue of 42,212,712.

Question 4

Silence Therapeutics PLC est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Silence Therapeutics PLC a un bénéfice net loss de $0

Question 5

Silence Therapeutics PLC a-t-elle des passifs ?

Accepted Answer

no, Silence Therapeutics PLC a un passif de 0

Question 6

Combien d'actions en circulation Silence Therapeutics PLC a-t-elle ?

Accepted Answer

Silence Therapeutics PLC a un total d'actions en circulation de 0

Breakdown	TTM
Revenue	45
Revenue Growth (YoY)	150%
Cost of Revenue	15
Gross Profit	29
Selling, General & Admin	46
Research & Development	126
Operating Expenses	173
Other Non Operating Income (Expenses)	24
Pretax Income	-139
Income Tax Expense	-3
Net Income	-136
Net Income Growth	202%
Shares Outstanding (Diluted)	141.69
Shares Change (YoY)	1%
EPS (Diluted)	-0.97
EPS Growth	202.99%
Free Cash Flow	--
Free Cash Flow Per Share	--
Gross Margin	64.44%
Operating Margin	-317.77%
Profit Margin	-302.22%
Free Cash Flow Margin	--
EBITDA	--
EBITDA Margin	--
D&A For EBITDA	--
EBIT	-143
EBIT Margin	-317.77%
Effective Tax Rate	2.15%

Silence Therapeutics PLC (SLN) Price

SLN Stock Price Chart

SLN Income

Follow-Up Questions